4//SEC Filing
NEIL GARRY ARTHUR 4
Accession 0001578563-24-000363
CIK 0001534120other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 4:00 PM ET
Size
8.8 KB
Accession
0001578563-24-000363
Insider Transaction Report
Form 4
NEIL GARRY ARTHUR
Chief Executive Officer
Transactions
- Award
Restricted Stock Units
2024-08-13+194,600→ 194,600 total→ Common Stock (194,600 underlying) - Award
Stock Option (Right to Buy)
2024-08-13+500,400→ 500,400 totalExercise: $9.88Exp: 2034-08-13→ Common Stock (500,400 underlying)
Holdings
- 60
Common Stock
Footnotes (3)
- [F1]The stock option vests 25% on March 28, 2025, and 1/36 monthly thereafter, subject to the Reporting Person's continued service on such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock upon the vesting date.
- [F3]The RSUs vest 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date.
Documents
Issuer
Avalo Therapeutics, Inc.
CIK 0001534120
Entity typeother
Related Parties
1- filerCIK 0001586785
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 4:00 PM ET
- Size
- 8.8 KB